Nelson G - Search Results

1

Surgical margin status in relation to surgical approach in the management of early-stage cervical Cancer: A Canadian cervical Cancer collaborative (4C) study.

Piedimonte S, Helpman L, Pond G, Nelson G, Kwon J, Altman A, Feigenberg T, Elit L, Lau S, Sabourin J, Samouelian V, Willows K, Aubrey C, Jang JH, Teo-Fortin LA, Cockburn N, Saunders NB, Shamiya S, Vicus D, Plante M; 4C: Canadian Cervical Cancer Collaborative. Piedimonte S, et al. Among authors: nelson g. Gynecol Oncol. 2023 Jul;174:21-27. doi: 10.1016/j.ygyno.2023.03.005. Epub 2023 May 3. Gynecol Oncol. 2023. PMID: 37146436

2

Optimal debulking targets in women with advanced stage ovarian cancer: a retrospective study of immediate versus interval debulking surgery.

Altman AD, Nelson G, Chu P, Nation J, Ghatage P. Altman AD, et al. Among authors: nelson g. J Obstet Gynaecol Can. 2012 Jun;34(6):558-566. doi: 10.1016/S1701-2163(16)35272-0. J Obstet Gynaecol Can. 2012. PMID: 22673172

3

Uterine sarcoma and aromatase inhibitors: Tom Baker Cancer Centre experience and review of the literature.

Altman AD, Nelson GS, Chu P, Nation J, Ghatage P. Altman AD, et al. Int J Gynecol Cancer. 2012 Jul;22(6):1006-12. doi: 10.1097/IGC.0b013e31825b7de8. Int J Gynecol Cancer. 2012. PMID: 22740004 Review.

4

Use of aromatase inhibitors as first- and second-line medical therapy in patients with endometrial adenocarcinoma: a retrospective study.

Altman AD, Thompson J, Nelson G, Chu P, Nation J, Ghatage P. Altman AD, et al. Among authors: nelson g. J Obstet Gynaecol Can. 2012 Jul;34(7):664-72. doi: 10.1016/s1701-2163(16)35320-8. J Obstet Gynaecol Can. 2012. PMID: 22742486

5

Architectural patterns of ovarian/pelvic high-grade serous carcinoma.

Bromley AB, Altman AD, Chu P, Nation JG, Nelson GS, Ghatage P, Kalloger SE, Han G, Köbel M. Bromley AB, et al. Among authors: nelson gs. Int J Gynecol Pathol. 2012 Sep;31(5):397-404. doi: 10.1097/PGP.0b013e31824c2372. Int J Gynecol Pathol. 2012. PMID: 22833078

6

MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome.

Nelson GS, Pink A, Lee S, Han G, Morris D, Ogilvie T, Duggan MA, Köbel M. Nelson GS, et al. Gynecol Oncol. 2013 Nov;131(2):309-14. doi: 10.1016/j.ygyno.2013.08.003. Epub 2013 Aug 11. Gynecol Oncol. 2013. PMID: 23938375

7

The effects of anemia and blood transfusion on patients with stage III-IV ovarian cancer.

Altman AD, Liu XQ, Nelson G, Chu P, Nation J, Ghatage P. Altman AD, et al. Among authors: nelson g. Int J Gynecol Cancer. 2013 Nov;23(9):1569-76. doi: 10.1097/IGC.0b013e3182a57ff6. Int J Gynecol Cancer. 2013. PMID: 24100588

8

PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.

McIntyre JB, Nelson GS, Ghatage P, Morris D, Duggan MA, Lee CH, Doll CM, Köbel M. McIntyre JB, et al. Gynecol Oncol. 2014 Jan;132(1):188-93. doi: 10.1016/j.ygyno.2013.11.015. Epub 2013 Nov 19. Gynecol Oncol. 2014. PMID: 24262879

9

POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium.

Meng B, Hoang LN, McIntyre JB, Duggan MA, Nelson GS, Lee CH, Köbel M. Meng B, et al. Gynecol Oncol. 2014 Jul;134(1):15-9. doi: 10.1016/j.ygyno.2014.05.006. Epub 2014 May 16. Gynecol Oncol. 2014. PMID: 24844595

10

Time to surgery and the risk of cancer progression in patients with gynaecologic cancers of the lower genital tract.

Vair B, Altman AD, Nelson G. Vair B, et al. Among authors: nelson g. J Obstet Gynaecol Can. 2015 Apr;37(4):338-44. doi: 10.1016/s1701-2163(15)30284-x. J Obstet Gynaecol Can. 2015. PMID: 26001687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,909 results

Search Page

Filters